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ABSTRACT
   Heterotrimeric G proteins are a family of guanine nucleotide-binding and catalysing proteins,
which transduce extracellular signals from G protein-coupled receptors into the intracellular
signalling pathways. Heterotrimeric G proteins consist of a, b and g subunits and take part in
the regulation of various physiological processes such as cell growth, hormonal regulation,
sensory perception and neuronal activity. Based on the structural and functional differences
between the a subunits, G proteins are classified in different families, with the Gi family being
the most diverse.
   Gi family subunit Gai2 shows a ubiquitous distribution in rat and particular enrichment in
ciliated cells in different tissues. The role of Gai2 in peripheral tissues has been intensively
studied, but the potential cilia-related role has remained unresolved. The aim of this study was
to clarify the physiological role of Gai2 in rat brain ependymal cilia and to uncover the
mechanisms controlling ependymal ciliary function. Furthermore, the study aimed to elucidate
the characteristics of Gai2 in ciliated reproductive tissues in human female.
   In order to clarify the role of Gai2 in brain homeostasis, the function of the Gai2 gene was
silenced by using continuous in vivo antisense administration. The effect of Gai2 knock-down
and the effect of selected compounds on the ependymal ciliary function were studied using rat
primary ependymal cell cultures. The presence of Gai2 in human female reproductive tissues
was studied using molecular biology tools and the localization of Gai2 was verified by
immunohistochemistry.
   This study revealed a cilia-related physiological role for Gai2. The results showed that Gai2
regulates CSF homeostasis in rat brain in vivo and ciliary beat frequency in rat brain ependymal
cells in vitro. Further, this study revealed for the first time a receptor-mediated inhibition of
ependymal ciliary function by PACAP27 and involvement of a cAMP-dependent pathway in the
regulation of ciliary amplitude. Furthermore, this study unveiled the localization of Gai2 in
female reproductive tissues in human, including endometrium and Fallopian tube epithelium,
with specific enrichment in the Fallopian tube cilia and endometrial glands. Gai2 was shown to
follow hormonal regulation during the menstrual cycle. Estradiol was shown to up-regulate Gai2
gene expression in immortalised human oviductal epithelial cell line OE-E6/E7.
   In summary, Gai2 has a cilia-related physiological role in rat brain and it is hormonally
regulated in the human female reproductive tract.
National Library of Medicine Classification: QU 55.2, QS 532.5.E7, WL 307, WP 300, WP 400
Medical Subject Headings: Heterotrimeric GTP-Binding Proteins; GTP-Binding Protein alpha
Subunit, Gi2 / physiology; Cilia; Brain; Ependyma; Cells, Cultured; Rats; Homeostasis; Gene
Silencing; Pituitary Adenylate Cyclase-Activating Polypeptide; Female; Endometrium;
Fallopian Tubes; Menstrual Cycle; Estradiol; Up-Regulation
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1 INTRODUCTION
   During evolution, a crucial step in the development of multicellular
organisms has been the cells’ ability to communicate. Cell-surface-
receptors play a crucial role in cell-to-cell-signalling by transducing the
extracellular, chemical and physical signals into the intracellular signalling
pathways. The largest group of membrane-bound signalling components
are G protein-coupled receptors (GPCRs) which have a characteristic,
seven transmembrane spanning structure (Alberts et al., 2002; Hill, 2006).
   GPCRs take part in membrane-mediated cell-signalling and regulation of
various physiological effects such as cell growth, hormonal regulation,
sensory perception and neuronal activity. GPCRs are activated by
extracellular ligands and they mediate their effects into the intracellular
pathways via heterotrimeric G proteins (Hepler and Gilman, 1992). Due to
diversity of GPCRs and their pathways, GPCRs are considered to be the
largest and the most important group of drug targets (Jacoby et al., 2006).
   Structure of heterotrimeric G proteins is well preserved during evolution,
which implies fundamental physiological roles. Indeed, dysregulation of G
protein pathways may contribute to diseases like cancer, hypertension,
cardiovascular diseases and endocrine disorders (Melien, 2007).
   Heterotrimeric G proteins are classified into four subfamilies, of which
the Gi family is the most diverse. Many G protein subunits are very closely
related, which makes the studies on their diverse roles challenging. Gi
family subunits Gai1, Gai2 and Gai3 are more than 85% identical, and show
wide, perhaps even ubiquitous distribution (Hepler and Gilman, 1992;
Wilkie et al., 1992). However, the Gai2 subtype is specifically localized in
rat tissues bearing motile cilia with the 9+2 ultrastructure. There is also
evidence of its presence in human tracheal cilia (Shinohara et al., 1998;
Ostrowski et al., 2002). This implies that it has a cilia-related physiological
role. Studies on the role of Gai2 have mainly focused on peripheral
functions, while its role in the central nervous system (CNS) or in the cilia
has remained largely obscure.
   One reflection of the highly conserved structure and mechanisms of
ciliary function is the fact that cilia-related genetic defects can cause a
variety of health problems in different tissues. Patients with primary ciliary
dyskinesia (PCD) have immotile or dysfunctional cilia, and suffer from a
combination of symptoms, such as recurrent respiratory infections,
hydrocephalus, reduced fertility and situs inversus (Ibañez-Tallon et al.,
2003; Chodhari et al., 2004). Despite the importance of epithelial cilia in
18
host defence against pathogens and other functions, there is little
information available on the regulation of ciliary function.
   This literature review gives an overview of current knowledge on G
protein Gai2 and its physiological role. Gene manipulation methods are
shortly reviewed, with emphasis on gene knockdown technique by
antisense oligonucleotides. Additionally, the structure and function of
mammalian motile cilia with the characteristics in different tissues are
reviewed.
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2 REVIEW OF LITERATURE
2.1 G protein-coupled receptors
2.1.1 Overview of G protein-coupled receptors
   GPCRs are the most widespread and diverse group of cell-surface-
receptors. They mediate messages from ligands as diverse as
neurotransmitters, local transmitters, hormones, peptides, lipids, taste
molecules, odorants, photons and growth factors (Flower, 1999). GPCRs
form the largest known gene superfamily in humans, with up to 850 genes
encoding for functional GPCRs (Venter et al., 2001; Foord et al., 2005).
   According to their amino acid sequences, GPCRs can be divided in four
classes: class A (rhodopsin-like), class B (secretin-like), class C
(metabotropic glutamate receptor-like) with the fourth class being named
“the frizzled” type (Foord et al., 2005). One characteristic of all GPCRs is
the seven a-helical transmembrane domain (7-TM) structure. The
receptors’ hydrophobic polypeptide chain forms three intracellular and
three extracellular loops, which have a flexible structure so that they can
interact with a diversity of ligands and G proteins (Bourne, 1997; Bockaert
and Pin, 1999). The N-terminal end of the polypeptide is located on the
extracellular side and is involved in ligand recognition, together with the
extracellular loops and the transmembrane structures (Bockaert and Pin,
1999). The intracellularly located C-terminus is needed for the receptor-G
protein interaction, as are the intracellular loops (Bourne, 1997).
   Classically, GPCR function has been seen as chain of events, starting
from receptor activation by an extracellular ligand, followed by the
receptor-G protein interaction and the consequent G protein activation.
Finally, the G protein interaction with its effector changes the intracellular
functions (Hepler and Gilman, 1992). Recently, however, increasing
evidence has accumulated that GPCRs interact not only with different G
proteins but also with various other proteins called GPCR interacting
proteins (GIPs). GIPs may be transmembrane proteins, sytosolic soluble
proteins or even other GPCRs. Most often GIPs interact with C-terminus,
which thus regulates GPCR functions via the GPCR-GIP interaction
(Bockaert et al., 2004b). The functional significance of numerous GIPs
remains to be established. GIPs are implicated in fine-tuning of GPCR
signalling, as well as GPCR trafficking and targeting (Bockaert et al.,
2004a; Bockaert et al., 2004b).
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   Over a decade, GPCRs have been assumed to exist in multimeric forms
(Rodbell, 1992), and lately, functional dimeric forms of GPCRs have been
shown to exist in vivo (Waldhoer et al., 2005). The functions and
significance of homo- and heterodimeric GPCRs still remain largely a
mystery (Milligan, 2004), but they are believed to diversify the
pharmacological responses and to fine-tune GPCR signalling and
specificity (Couve et al., 2004).
2.1.2 Overview of heterotrimeric G proteins
   G proteins belong to a family of guanine nucleotide (GDP, GTP)-binding
and hydrolysing proteins. Small, monomeric G proteins do not couple to
receptors but are involved in the regulation of cellular development and
function (Alberts et al., 2002). Heterotrimeric G proteins consist of three
peptide subunits, a, b and g which couple to GPCRs. The GTP-binding and
hydrolysing a subunits have been best characterized and are unique to each
G protein (Gilman, 1987). Based on the amino acid sequence of a subunits,
as well as the signalling cascade involved, G proteins are divided into four
subfamilies, Gi, Gs, Gq and G12 (Wilkie et al., 1992; Wong, 2003). The
characteristics of different Ga subunits within the families are presented in
Table 1.
   One crucial feature for G protein function is their ability to bind GTP and
to catalyse its hydrolysis to GDP (Cabrera-Vera et al., 2003). In their
resting state, heterotrimeric G proteins become attached to the intracellular
face of plasma membrane as a abg complex, in which the a subunit binds
GDP and the bg dimer stabilises the structure (Clapham and Neer, 1993).
Once a ligand binds to GPCR, the heterotrimeric G protein undergoes a
conformational change that facilitates the Ga interaction with the receptor.
Activated Ga exchanges GDP to GTP, and this leads to the dissociation of
Ga and bg subunits. Both activated Ga-GTP and the bg dimer mediate
independently their downstream signalling to effector proteins. The
intrinsic GTPase activity of the Ga subunit enables Ga to return to its
inactive, GDP-binding state in which it can re-associate with the bg dimer
(Cabrera-Vera et al., 2003).
   The role for both Ga-GTP and bg is to mediate the signal from the
activated GPCR to the effector protein, which can be an enzyme or an ion
channel. Effector proteins mobilize second messengers, which then trigger
the characteristic molecular events and modify cellular functions (Hepler
and Gilman, 1992). Each G protein family has its characteristic signalling
pathways; the Gs family  stimulates  adenylyl  cyclase  (AC),  while  the  Gi
21
Table 1. Characteristics of G protein families. Effectors represent the intracellular
pathways into which the G protein family members are coupled. Bacterial toxins to
which the G protein subunits show sensitivity are listed. AC = adenylyl cyclase, PLC =
Phospholipase C, PLCb = Phospholipase Cb, PLA2 = Phospholipase A2, PDE =
Phosphodiesterase, CTX = Cholera toxin, PTX = Pertussis toxin. Based on Hepler and
Gilman (1992) and Malbon (2005).
Family Members
/ subunits
Mass
(kDa)
Distribution Effectors Toxin
as 44.2 Ubiquitous AC ?, Ca
2+ channels ?, Na+
channels ?
CTX
asXL 45.7 Ubiquitous,
neuroendocrine
tissues
AC ?, Ca2+ channels ?, Na+
channels ?
CTX
Gs
aolf 44.7 Olfactory
epithelium, brain
AC ? CTX
ai1 40.3 Widely distributed K+ channels ?, Ca
2+ channels
?, AC ?, PLC ?, PLA2??
PTX
ai2 40.5 Ubiquitous K+ channels ?, Ca
2++
channels ?, AC ?, PLC ?,
PLA2??
PTX
ai3 40.5 Widely distributed K+ channels ?, Ca
2+ channels
?, AC ?, PLC ?, PLA2??
PTX
aoA 40.0 Neuronal &
neuroendocrine
tissues
K+ channels ?, Ca2+ channels
?, AC ?, PLC ?, PLA2??
PTX
aoB 40.1 Neuronal &
neuroendocrine
tissues
K+ channels ?, Ca2++
channels ?, AC ?, PLC ?,
PLA2??
PTX
at1 40.0 Retinal rods,
taste cells
cGMP-specific PDE ? CTX, PTX
at2 40.1 Retinal cones,
stem cells
cGMP-specific PDE ? CTX, PTX
agust 40.5 Taste buds PDE ? PTX
Gi
az 40.9 Brain, platelets AC ? ?
aq 42 Ubiquitous PLCb??
a11 42 Ubiquitous PLCb??
a14 41.5 Lung, kidney, liver,
spleen
PLCb??
Gq
a15/16 43 Hematopoietic cells PLCb??
a12 44.0 Ubiquitous
Rho guanine nucleotide-
exchange factors ?
G12
a13 44.0 Ubiquitous Rho guanine nucleotide-
exchange factors ?
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family inhibits AC and regulates ion channels (Figure 1). The Gq family
activates PLC and the G12/13 family activates signalling of small,
monomeric G protein Rho (Knall and Johnson, 1998). The Gi family is the
most widespread and diverse of the G protein families.
   In addition to GPCRs, G proteins can be activated by proteins called
activators of G protein signalling (AGS) (Blumer et al., 2007). AGS
signalling can activate the heterotrimeric G proteins independently of
receptor activation (Takesono et al., 1999). AGS has been proposed as
having a role in the facilitation of signalling, though the ultimate
significance of this protein family in signal processing remains to be
clarified (Blumer et al., 2007).
Figure 1. Function of Gs and Gi proteins in the regulation of AC. a) Binding of agonist
noradrenaline (NE) to b receptor causes Gs activation and subsequently, AC activation.
This increases cyclic AMP (cAMP) production which has many intracellular effects,
e.g. it can activate protein kinase A (PKA) b) When NE binds to a2 receptor, it evokes
Gi activation and adenylyl cyclase inhibition. Reprinted from Bear et al. (2001) with
permission from Lippincott, Williams & Wilkins.
   The activity of G proteins can be regulated by proteins named regulators
of G protein signalling (RGS) (Druey et al., 1996). RGS efficiently inhibit
G protein signalling and thus can control mediation of signals from
GPCRs. The main mechanism of action for RGS is functioning as a
GTPase-accelerating protein (GAP), which involves binding to Ga subunit
to evoke its rapid deactivation (Berman et al., 1996) and as a result, the
time that Ga remains in its active form is shortened. Alternatively, RGS
may competitively inhibit G protein binding to effectors (Huang et al.,
1997). New ways to modify G protein function are emerging. A recent
23
study showed that Gai3 subunit inhibits Gai2 activation in a competitive
manner. This provides the possibility of regulatory roles for the Ga
subunits in the control and modulation of each others’ signalling
(Thompson et al., 2007).
2.2 G protein subunit ai2
2.2.1 General characteristics of Gai2
   The G protein subunit Gai2 shares more than 85 % amino acid identity
with the closely related Gi subunits Gai1 and Gai3 (Hepler and Gilman,
1992; Wilkie et al., 1992). Despite the similarities, all three subunits are
encoded by separate genes (Suki et al., 1987; Itoh et al., 1988b). Gai2 was
characterized in 1986 by molecular cloning in rat brain C6 glioma cells
(Itoh et al.) and then in mouse (Sullivan et al., 1986), man (Didsbury et al.,
1987; Itoh et al., 1988b) and pig (Itoh et al., 1988a).
   An unstable splice variant for Gai2, named sGai2, has been characterized
(Montmayeur and Borrelli, 1994; Wedegaertner, 2002). Gai2 and sGai2
differ solely at their extreme C-terminus, where the splice variant has 35
novel amino acids replacing the normal 24 amino acids. sGai2 has been
shown to localize in mouse testis (Montmayeur and Borrelli, 1994) and to
be widely expressed in rat and monkey brain (Khan and Gutierrez, 2004).
However, it seems to degrade rapidly and to be unable to associate with
cell membranes (Wedegaertner, 2002).
   mRNA and protein localization studies have revealed that Gai2 has a
ubiquitous distribution in various rat and human tissues and cell lines
(Brann et al., 1987; Kim et al., 1988; Asano et al., 1989; Garibay et al.,
1991; Shinohara et al., 1998). The fact that Gai2 gene promoter region
resembles typical housekeeping gene promoters may contribute to its
ubiquitous distribution (Weinstein et al., 1988). Gai2 seems to be enriched
in tissues with motile cilia, such as brain ependymal cells, trachea and
oviducts (Shinohara et al., 1998), pointing to a specific role in ciliary
function.
   Tissue-specific Gai2 knock-down (Moxham et al., 1993), creation of Gai2
knock-out mice (Jiang et al., 1997), and creation of transgenic mice with
constitutively active Gai2 (Chen et al., 1997) have helped to elucidate the
role of Gai2, especially in peripheral tissues. The following chapters will
summarize the current knowledge on the role of Gai2 in various systems.
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2.2.2 Role of Gai2 in cell growth and development
   Studies on knock-down and knock-out mice have demonstrated the
necessity of Gai2 for both neonatal (Moxham et al., 1993) and postnatal
growth in vivo (Rudolph et al., 1995a). Its critical role in growth and
development is supported by the fact that a simultaneous deficiency of Gai2
and Gai3 evokes embryonic lethality (Wettschureck et al., 2004).
   The closely related Gai1, Gai2 and Gai3 have been shown to localize in
centrosomes and the midbody in different cell lines and participate in
cytokinesis (Cho and Kehrl, 2007). However, no specific role for Gai2 in
cytokinesis has been defined. With respect to cell division, it has been
reported that Gai2 stimulates mitogen-activated protein kinase (MAPK)
cascade (Pace et al., 1995).
   Gai2 regulates the differentiation of mice teratocarcinoma stem cells
(Watkins et al., 1992; Gao et al., 1995) and human hematopoietic cell line
(Davis et al., 2000). There is also evidence that Gai2 can enhance the
proliferation of neural progenitors (Shinohara et al., 2004), and regulate the
development of liver and fat (Moxham et al., 1993).
   A mutant, constitutively active form of Gai2 has been named gip2, and
has been proved oncogenic (Pace et al., 1991; Wong et al., 1991). Gip2 is
found in endocrine tumours and adrenal cortex tumours in human (Lyons et
al., 1990), which strongly links Gai2 function with growth promotion.
Additionally, the key role of Gai2 in insulin signalling (reviewed in chapter
2.2.4) further suggests that Gai2 is essential in the regulation of growth and
development.
2.2.3 Role of Gai2 in cardiovascular system
   In mouse heart, Gai2 regulates the muscarinic inhibition of cell
contractility and L-type Ca2+ currents (Nagata et al., 2000; Chen et al.,
2001). In human cardiac failure, when the stimulatory catecholamine
effects mediated by b1 and b2 adrenergic receptors are compromised, there
is an increase in Gi protein levels (Feldman et al., 1988; Neumann et al.,
1988). Furthermore, Gai2 is involved in the cardioprotective effects of
chronic adrenergic b2-adrenoceptor signalling (Foerster et al., 2003).
   Gai2 is present in platelets and platelet precursors, megakaryocytes.  It
has also been found in a human erythroleukemia cell line (Williams et al.,
1990). Gai2 is pivotal in platelet aggregation via its interaction with ADP
receptor P2Y12 (Jantzen et al., 2001; Yang et al., 2002). The role of Gai2
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with regard to its regulatory functions in leukocytes is reviewed in chapter
2.2.7.
2.2.4 Role of Gai2 in insulin signalling
   Gai2 has a central role in insulin signalling and it couples to insulin
receptors (Krieger-Brauer et al., 1997; Sanchez-Margalet et al., 1999). Gai2
positively regulates insulin action, improving glucose tolerance and
decreasing insulin resistance (Moxham and Malbon, 1996). Constitutively
active Gai2 in transgenic mice has been reported to mimic actions of insulin
signalling in mice (Chen et al., 1997; Guo et al., 1998). In human adipocyte
membranes, insulin has been shown to recruit Gai2 to modulate tyrosine
kinase activity, and thus to regulate the autophosphorylation of insulin
receptors (Kreuzer et al., 2004).
2.2.5 Role of Gai2 in respiratory tract
   Information on the roles of Gai2 in respiratory tract is limited, but it
seems to take part in growth and development of fetal airway epithelium
(Kinane et al., 1999). Furthermore, proteomic analysis has shown that Gai2
is a resident axonemal protein in human bronchial cilia (Ostrowski et al.,
2002). Some Gai2 deficient mice have been reported to die of pneumonia
(Rudolph et al., 1995a), but this may be due to their severely impaired
immune system rather than to any problems in tracheal ciliary function.
2.2.6 Role of Gai2 in central nervous system
   Generally, G?i2 seems to be ubiquitous in most tissues (Asano et al.,
1989), but its localization in brain is restricted. In rat, G?i2 is localized in
the subventricular zone, the rostral migratory stream (Asano et al., 2001),
the accessory olfactory bulb (Shinohara et al., 1992) and the ependymal
cilia (Shinohara et al., 1998). Gai2 mRNA have also been reported in rat
choroid plexus (ChP), hippocampus, cerebellum and cortex (Brann et al.,
1987). In rat brain, Gai2 protein levels are high already prior to birth, and
they remain relatively constant or slightly increase until the age of 3
months (Asano et al., 1989; Ihnatovych et al., 2002).
   The role of G?i2 in the CNS has remained largely unexplored. There is
evidence that a pertussis toxin-sensitive G protein, assumed to be Gai2, is
involved in neural stem cell proliferation in the rat subventricular zone
(Shinohara et al., 2004). Transgenic mice with constitutively active Gai2
have provided evidence that Gai2 takes part in the suppression of synaptic
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transmission. This takes place via metabotropic glutamate receptor 2
(mGluR2) and results in enhanced long-term depression and inhibition of
long-term potentiation (Nicholls et al., 2006).
2.2.7 Role of Gai2 in immunology
   The role of Gai2 in immunology has been investigated intensively, and
studies on knock-out mice have revealed that Gai2 has a crucial role in
immunological responses. Gai2 has a key role in T cell proliferation and
functions (Jiang et al., 1997; Zhang et al., 2005), cytokine and chemokine
production and signalling (Han et al., 2005; Fan et al., 2006, 2007) as well
as in leukocyte extravasation (Pero et al., 2007). Furthermore, Gai2 has
been shown to regulate B cell functions (Han et al., 2005) and to mediate
Arthus reaction (Skokowa et al., 2005). An anti-inflammatory role in the
regulation of Toll-like receptor (TLR) signalling has also been proposed,
but the regulatory mechanism remains unknown (Fan et al., 2005).
   Mice deficient of Gai2 (Moxham et al., 1993; Jiang et al., 1997) exhibit a
pro-inflammatory phenotype and develop severe immunological problems
such as fatal inflammatory bowel disease (Rudolph et al., 1995a; Rudolph
et al., 1995b). Lack of Gai2 disturbs B cell development (Dalwadi et al.,
2003) and regulation of T cell function (Wu et al., 2005). The altered
immune responses have been proposed to account for the susceptibility of
Gai2 knockout mice to this disease. In humans, Gai2 gene has been
proposed as potential candidate gene for human inflammatory bowel
disease (IBD) (Dalwadi et al., 2003; Wu et al., 2005), because the
localization of Gai2 at chromosome 3p21 overlaps with IBD susceptibility
loci (Hampe et al., 2001).
2.2.8 Role of Gai2 in reproduction
   The first evidence of Gai2 in mammalian reproductive tissues was in rat
myometrial membranes (Milligan et al., 1989). Later, differential
modulation of Gai2 and Gai3 in rat myometrium during gestation was
reported (Tanfin et al., 1991). In human myometrium, the levels of Gai2
decrease during pregnancy and simultaneously, myometrial Gs substantially
increases, suggesting that the balance between Gai2 and Gs might be
important in the regulation of uterus relaxation during pregnancy (Europe-
Finner et al., 1993). Gi family proteins have been suggested to be
functionally linked to a2 adrenergic signalling in human myometrium
during pregnancy (Breuiller et al., 1990). In the pregnant rat, the
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involvement of Gai2 and Gai3 in a2/b2 adrenergic signalling in the
maintenance of uterus relaxation has been demonstrated (Mhaouty et al.,
1995). Although the role of G?i2 in the myometrium has been thoroughly
studied, the presence or the role of Gai2 elsewhere in the human
reproductive tract remains unclear.
   In human sperm, Gai2 is localised in the acrosome as well as in midpiece
and tailpiece of spermatozoa (Merlet et al., 1999). It seems that Gai2 has no
effect on sperm motility, since motility is not a pertussis toxin (PTX)-
sensitive function. In contrast, PTX-sensitive G proteins have been claimed
to take part in the regulation of acrosome reaction (Lee et al., 1992;
Franken et al., 1996) as well as sperm capacitation (Fraser and Adeoya-
Osiguwa, 1999) and thus play an essential role in the early events in
fertilization. Further, AC and cAMP pathways seem to be involved in
sperm fertilizing ability (Fraser et al., 2005).
2.3 Gene silencing methods
2.3.1 Knockout method
   Genetic engineering methods have proved useful in clarifying the roles of
very closely related molecules. The technologies available include gene
overexpression, gene misexpression (gene expression at abnormal tissues
or at abnormal times), expression of mutant gene and gene knockout
(Alberts et al., 2002).
   Gene knockout is a widely used technology and involves disruption of
the targeted gene, leading to complete failure to express the final protein
product. Knockout method allows deletion of selected gene either from the
entire genome, or locally, within a specific tissue of interest. Further, a
gene can be deleted in an inducible fashion at a desired age of animal or at
a certain time point (Beglopoulos and Shen, 2004).
   In particular, the complete gene deficiency may prove problematic, as the
animals lack the targeted gene through all stages of their development.
Thus, the development of compensatory mechanisms is likely, and
embryonic lethality is not uncommon. Furthermore, creating a knockout
animal is time-consuming, expensive and technically demanding (Van
Oekelen et al., 2003; Plum et al., 2005). The method has also been
criticized for its limitations in result interpretation, as even the same
genetic mutation produces different phenotypes in different strains.
Furthermore, the brother-sister mating used to maintain the transgenic lines
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may result in a genetic background that cannot be reproduced in controls
(Hickman-Davis and Davis, 2006).
   With respect to studies of Gai2 protein, mice with Gai2 deficiency (Jiang
et al., 1997) and transgenic mice with constitutively active Gai2 (Chen et
al., 1997) have been created. Furthermore, tissue-specific transgenic mice
with inducible mutant form of Gai2 have been created to reveal the role of
Gai2 in insulin signalling (Moxham et al., 1993; Moxham and Malbon,
1996). Mice deficient of Gai2 have been reported to compensate for the
lack of Gai2 by increased synthesis of Gai3 protein (Rudolph et al., 1996).
2.3.2 Knockdown methods
2.3.2.1 Antisense-oligonucleotides
   Gene knockdown is defined as suppression of gene product through
specific targeting of the ribonucleic acid (RNA) product of the gene. This
can be achieved in a selected time window using antisense
oligonucleotides, ribozymes or RNA interference (RNAi) (Crooke, 1999;
Steele et al., 2003; Dykxhoorn and Lieberman, 2005).
   Antisense oligodeoxynucleotides (AS-ODNs) are targeted towards the
selected messenger RNA (mRNA) sequence and can be used to temporarily
disrupt gene function. The most common mechanism of interference is
endonucleolytic cleavage of the target mRNA by an endogenous RNase H
activity, leading to a decrease in full-length target mRNA and thus,
decreased synthesis of the corresponding protein (Baker and Monia, 1999).
The effects of AS-ODNs in the cells are attributed to a loss of the targeted
proteins (Crooke, 1999), but equally important may be the synthesis of
truncated and thus dysfunctional target protein (Thoma et al., 2001).
   Major challenges for antisense oligonucleotide-based gene knockdown
method are finding an optimal target region in the gene and selecting an
optimal oligonucleotide length. Once the problem of oligonucleotide design
has been solved, the methodology is applicable to any species and at any
developmental stage, provided that the targeted genomic sequence is
known. In comparison with the knockout method, the advantages of using
antisense oligonucleotides are savings in cost and time as well as the
feasibility for use in a variety of species (Rohrer and Kobilka, 1998).
   Oligonucleotides presumably enter the cells via endocytosis and
pinocytosis. When a carrier is not being used to facilitate cell entry,
concentrations of AS-ODNs needed in cell culture applications are
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significantly higher than those required for carrier-mediated effect, µM vs.
nM, respectively (Stein, 1999). Potentially, even higher local
concentrations are needed for effective treatments in vivo. Frequently this
means that constant delivery or delivery at regular intervals is required,
especially when stable derivatives are not used. On the other hand, rapid
degradation can also be seen as an advantage, since it makes the antisense
approach very regulatable (Van Oekelen et al., 2003).
   Various modifications in the oligonucleotide structure have been
attempted to improve the stability, and thus to enable the use of lower
concentrations. Increased stability may, however, result in toxic effects and
also alter oligonucleotide specificity (Crooke, 1999). Extensively used
phosphorothioate-modified oligodeoxynucleotides (ODNs) have proved
toxic in many systems, and that limits their usefulness in in vivo
applications (Agrawal, 1999). Many modifications with improved
properties, such as morpholino antisense oligonucleotides, peptide nucleic
acids and locked nucleic acids have been introduced. Morpholinos are
nuclease-resistant and provide efficient and specific knockdown
(Summerton, 1999). Peptide nucleic acids have a modified polymer
backbone instead of standard deoxyribose phosphate, permitting better
stability, high specificity and affinity. However, peptide nucleic acid
oligonucleotides have suffered from poor cellular uptake and thus might
require a carrier to enter the cells (Larsen et al., 1999). Locked nucleic
acids structurally mimick RNA monomers and have increased thermal
stability. This appears to render them stable, potent and non-toxic
(Wahlestedt et al., 2000).
   While the majority of antisense oligonucleotides disrupt gene function by
RNase H activity, the modified oligonucleotides can be an exception. For
instance, the sugar and sugar-phosphate backbone modifications are not
substrates for RNase H and thus the antisense effect is obtained via an
alternative disruption mechanism, such as inhibition of splicing,
translational arrest or induced cleavage (Baker and Monia, 1999; Crooke,
1999). Presumably, many mechanisms for AS-ODN function may be
simultaneously involved in prevention of protein synthesis (Van Oekelen et
al., 2003).
   Intracerebroventricular (i.c.v.) AS-ODN delivery has been widely used in
neuroscience, as it allows the bypassing of the blood brain barrier.
However, the challenges with this approach are not only the stability of
AS-ODN, as that may be partially overcome by using modified
oligonucleotides, but also tissue penetration and distribution in brain
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parenchyma. However, there is strong evidence that AS-ODNs can
gradually spread to brain regions adjacent to the ventricles (Sakai et al.,
1995; Chauhan, 2002; Van Oekelen et al., 2003). AS-ODN degradation
seems to be less active in CSF when compared to brain tissue and
furthermore, some modified AS-ODNs have better resistance against
nucleases than unmodified AS-ODNs (Whitesell et al., 1993). However,
constant delivery or repeated administration is frequently required. The
same applies to other gene knockdown methods, as also small interfering
RNAs (siRNAs) have been reported to require continuous delivery to
achieve stable effects following i.c.v. administration in mice (Thakker et
al., 2004).
   In order to discriminate the true antisense effects from the undesirable
non-specific effects, the use of control oligonucleotides is necessary.
Preferably at least two different sense or mismatch oligos should be used.
The reversibility of the effect is usually considered as the most crucial
antisense control. As soon as no oligonucleotides are present in the target
cells, gene expression and the resulting protein synthesis should return to
normal. If desired, a second AS-ODN against the same gene, but targeted at
a different segment of mRNA, can be used as a positive control.
Furthermore, for control purposes, downregulation of the target gene is
usually proved by Western blotting. Alternatively, downregulation of
mRNA can be studied by using Northern blotting or polymerase chain
reaction (Stein, 1999; Van Oekelen et al., 2003).
2.3.2.2 RNA interference
   The most recently introduced method for gene knockdown is RNA
interference, which is based on a cellular defence mechanism against
foreign RNA, like viruses. The presence of foreign, double-stranded RNA
sequences triggers enzymatic degradation into small RNA fragments,
followed by a cleavage mechanism to recognise and destroy all of the
sequences complementary to the original sequences (Alberts et al., 2002).
   The system can be utilized for knockdown by delivering small, double-
stranded RNA of the desired sequence into the cells via a vector-based
approach. Similarly to foreign double stranded RNA, also mRNA produced
by the targeted cell will be degraded if its sequence matches the foreign
RNA. Thus, the selected mRNA target can be cleaved from the cell and as
a result, protein synthesis will be inhibited (Alberts et al., 2002; Pei and
Tuschl, 2006).
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   The interfering RNA sequence is referred to as siRNA, and it can be
introduced to cells in various modified forms, such as short hairpin RNA
(shRNA). As siRNAs do not cross cell membranes, the challenge to this
technique is to find a suitable means for delivery. Viral vectors are
frequently used, as are different siRNA complexes with lipids and delivery
proteins (Dykxhoorn and Lieberman, 2005; Snøve and Rossi, 2006). One
major advantage of RNAi is its controllability. Gene expression can be
conditionally silenced at any timepoint by using external activation, such as
induction by a drug (Wiznerowicz et al., 2006).
   Since RNAinterference is universal and a conserved mechanism in
eukaryotic cells, it has potential for therapeutic use (Dykxhoorn and
Lieberman, 2005). In the future, RNA interference may well become a
useful tool in the treatment of a variety of illnesses, even neurological
disorders. For example, a recent study showed that a peptide-bound siRNA
allowed transvascular delivery across the blood brain barrier (Kumar et al.,
2007). This finding may well open up new avenues for delivery of gene
therapy vectors.
2.4 Mammalian motile cilia
2.4.1 Structural features of the cilia
   Cilia are microscopic organelles which consist of a membrane enclosed
tube with well organized microtubule cytoskeleton, the axoneme. Cilia can
be classified into two main categories, epithelial cilia and primary cilia.
Generally, epithelial cilia are motile and found as groups of several
hundreds, while primary cilia are immotile and solitary. Epithelial cilia
typically serve as a clearance and defence function of the epithelia (Satir
and Christensen, 2007). Primary cilia can be further classified into sensory
and nodal cilia. Sensory cilia are immotile and serve as environmental
sensors. Nodal cilia are motile and have a crucial role in determining the
left-right axis during the embryonic development by propelling the
embryonic fluid (Chodhari et al., 2004).
   The structure of cilia and flagella is highly conserved among species and
between the different ciliated tissues (Figure 2). The basic structure of the
axoneme includes 9 peripheral microtubule doublets, usually surrounding
the two single microtubules in the central core. Based on the structure, cilia
are either called 9+2 or 9+0, the latter type lack the central pair of
microtubules. Generally, 9+2 cilia are motile and 9+0 cilia immotile, with
the exception of the 9+0 structured nodal cilia which display a rotational
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beating pattern (Satir and Christensen, 2007). Flagella are structured like
cilia, but are usually substantially longer, and their beating pattern differs
from that of cilia (Afzelius, 2004).
Figure 2. Ultrastructure of cilia is highly conserved in different tissues. This illustration
of the human male and female show the ciliary tissues which have been implicated in
human diseases involving malfunction of the cilia. Motile cilia in brain, respiratory tract
and Fallopian tube as well as sperm flagella share the typical 9+2 ultrastructure.
Reprinted from Ibañez-Tallon et al. (2003) with permission from Oxford University
Press.
   The ciliary axoneme is completed with structural components, dynein
arms, radial spokes and nexin links (Figure 3). Axonemal dyneins are
responsible for ciliary movement. During ciliary beating, the dynein arms
interact with microtubule doublets, making them slide with respect to one
another and thus creating the characteristic beating motility (Satir and
Christensen, 2007). The inner dynein arms are responsible for ciliary
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bending form, i.e. amplitude, while the outer dynein arms adjust the beat
frequency (Brokaw and Kamiya, 1987; Satir et al., 1995; Habermacher and
Sale, 1997). The inner microtubule pair in the central core of the axoneme
is presumably needed for back and forth motion, since their absence results
in rotational beating (Chilvers et al., 2003). Radial spokes interact with the
central microtubules, and nexin links with the microtubule doublets. This
allows for beat modification (Satir and Christensen, 2007).
   The ciliary membrane covering the axoneme is continuous with the cell
membrane, though it possesses a battery of signalling components which
differ from those in the cell membrane. Receptors and ion channels present
on the ciliary membrane are linked to various signalling pathways related
to motility, growth and differentiation. It is likely, that the sensory role of
cilia involves not only the immotile primary cilia, but also all motile cilia.
This assumption is supported by the fact that increasing amounts of
proteins have been identified as ciliary proteins and many of them are
presumably involved in signalling (Ostrowski et al., 2002; Salathe, 2007;
Satir and Christensen, 2007).
Figure 3. Diagram of the ciliary axoneme showing the central structure with
microtubules. Nine peripheral microtubule doublets surround the central pair, forming
the 9+2 structure. Reprinted from Afzelius et al. (1998) with permission from BMJ
Publishing group.
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   Intraflagellar transport (IFT) is crucial for ciliogenesis, cilia maintenance
and signalling. IFT is a microtubule-based machinery for molecule
transport and this process takes place beneath the ciliary membrane. Via
IFT, structural components are moved as cargo to the cilia tip, and channel
proteins and receptors are transported to the ciliary membrane. Specific
proteins named IFT particles are required for this process. Successful
movement of cargo requires that the transported molecules are associated
to IFT particles. Anterograde IFT transports the molecules to the cilia tip,
and retrograde IFT returns both IFT particles and axonemal turnover
products to the cilia base to be recycled (Scholey, 2003). The ciliary
necklace, a specialized region at the base of the cilium, is believed to act as
a loading zone for molecules destined for transport (Satir and Christensen,
2007).
   Evidence of highly conserved mechanisms of ciliary function is seen in
the fact that cilia-related genetic defects cause a variety of health problems
in different tissues. Genetic defects in cilia structure or function are
associated with disorders such as situs inversus, infertility, hydrocephalus,
anosmia and retinitis pigmentosa (Afzelius, 2004). PCD occurs in humans,
and also includes Kartagener's syndrome and immotile cilia syndrome. It is
characterized by many simultaneous cilia-related symptoms such as
sinopulmonary infections, hydrocephalus, situs inversus and reduced
fertility (Chodhari et al., 2004).
The following chapters will provide an overview of the roles and function
of motile cilia in different tissues, with the emphasis on brain ependymal
cilia and oviductal cilia.
2.4.2 Role and function of cilia in different tissues
2.4.2.1 Brain ependymal cilia
   Brain ventricles are lined with a one-cell layer consisting of ciliated
ependymal cells and non-ciliated tanycytes. In many species, the ependyma
proliferates early, during embryonic and early postnatal periods (Flament-
Durand and Brion, 1985; Bruni, 1998). In mice and rabbits, ependymal
cilia are fully developed by the first postnatal week (Tennyson and Pappas,
1962; Bruni, 1998; Spassky et al., 2005). After the proliferation period,
ependymal cells possess hardly any proliferation activity, and in humans,
ependyma evidently does not regenerate at any age (Sarnat, 1995).
   In the rat, ependymal cilia are 8 µm long (Figure 4) and they beat at a
frequency of around 40 Hz (O'Callaghan et al., 1999) in a coordinated
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manner, towards the nearest opening inside the ventricular cavity (Cathcart
and Worthington, 1964). There is a direct link between the ciliary beat
direction and the cerebrospinal fluid (CSF) flow direction (Cathcart and
Worthington, 1964; Yamadori and Nara, 1979). Ciliary beating has been
proven to be necessary for concentration gradient formation in CSF
guidance to permit proper migration of neuroblasts (Sawamoto et al.,
2006).
Figure 4. Rat brain ependymal cells
visualised using transmission electron
microscopy. Microvilli (arrow) and the cilia
(arrowheads) can be seen on the luminal
surface. Scalebar 2 µm (K.S. Mönkkönen,
unpublished).
   Over the decades, there has been a debate regarding the role of
microscopic cilia in the dynamics of CSF. However, there is increasing
evidence that a dysfunction of ependymal cilia can result in hydrocephalus.
For instance, mutant rats named WIC-Hyd exhibit immotile ependymal and
respiratory cilia, and suffer from congenital hydrocephalus (Koto et al.,
1987; Shimizu and Koto, 1992). Metavanadate, which acts as an inhibitor
of ciliary movement, can induce hydrocephalus in rats (Nakamura and
Sato, 1993). Furthermore, several studies have shown that hydrocephalus
results from deficiencies in cilia structural components, such as the
axonemal proteins Mdnah5 (Ibañez-Tallon et al., 2002; Ibañez-Tallon et
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al., 2004) or Spag6 (Sapiro et al., 2002). Similarly, hydrocephalus has been
demonstrated to result from deficiencies in the proteins involved in
ciliogenesis, such as Polaris (Taulman et al., 2001), HFH-4 (Chen et al.,
1998) and polymerase lambda (Kobayashi et al., 2002). The connection
between ciliary dysfunction and the development of hydrocephalus has
been clarified further, since loss of normal ciliary function in choroid
plexus in vivo has been demonstrated to result in disturbed cAMP-regulated
chloride transport, leading to excess CSF production and hydrocephalus
(Banizs et al., 2005). The role of ependymal cilia in CSF homeostasis is
supported by the fact that PCD patients frequently suffer from
hydrocephalus (Afzelius, 2004).
   Many pathogens are able to disturb brain homeostasis and evoke
hydrocephalus (Johnson and Johnson, 1968; Kohn et al., 1977). Direct
inhibition of ependymal ciliary function has been confirmed for
Mycoplasma pulmonis (Kohn and Chinookoswong, 1980) and for
Streptococcus pneumoniae. Furthermore, the bacterial toxin, pneumolysin,
from Streptococcus pneumoniae has been demonstrated to cause a rapid
ciliary stasis (Mohammed et al., 1999; Hirst et al., 2000; Hirst et al., 2004)
and loss of cilia during pneumococcal meningitis (Hirst et al., 2003).
   Despite its importance in CSF homeostasis and host defence against
pathogens, ependymal ciliary beat frequency (CBF) has been rarely
studied. Serotonin has been reported to cause a CBF increase in rats, while
adenosine triphosphate (ATP) and forskolin (FSK) decrease CBF (Nguyen
et al., 2001).
2.4.2.2 Oviductal cilia
   The oviduct luminal epithelium consists of two cell types, ciliated cells
(Figure 5) and non-ciliated secretory cells. During the human menstrual
cycle, Fallopian tubes undergo cyclic changes in response to fluctuations in
the ovarian steroid hormones (Verhage et al., 1979). Estrogen is known to
regulate epithelial cell differentiation, ciliogenesis, secretory activity as
well as hypertrophy, whereas progesterone induces deciliation and atrophy
(Verhage et al., 1979; Donnez et al., 1985).
   Fallopian tube cilia are approximately 10 µm long and the average CBF
in human is 5-6 Hz (Mahmood et al., 1998; Lyons et al., 2006b). There is
evidence that the cilia beat faster during the secretory phase (Critoph and
Dennis, 1977; Lyons et al., 2002), which suggests that ciliary movement is
involved in the transport of the ovum and the early embryo. Generally, the
motility of the epithelial cilia is considered as being essential in gamete
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transport in association with tubal secretory flow and muscle contractility
(Jansen, 1984). However, in animals with isoprenaline-induced inhibition
of tubal muscle contractility, the transit times through the ampulla do not
significantly change. This suggests that ciliary function alone is capable of
transporting the ovum in a normal time frame (Halbert et al., 1976; Halbert
et al., 1989). The vital role for cilia motility in fertilization is further
supported by the fact that patients with immotile cilia may suffer from
reduced fertility or infertility (Afzelius, 2004) and that patients with ectopic
pregnancies frequently have a reduced number of ciliated cells in their
Fallopian tubes (Vasquez et al., 1983).
Figure 5. Pig oviduct luminal epithelium showing Gai2 enrichment in the cilia (A).
Negative control (B). Scale bar 30 µm (K.S. Mönkkönen, unpublished).
   Fallopian tube epithelial cells are of special importance in the early
events of fertilization, since they are in direct cell-to-cell contact with the
gametes (Pacey et al., 1995a; Pacey et al., 1995b). Under in vitro
conditions, human sperm directly interact with and bind to Fallopian tube
ciliated cells (Baillie et al., 1997). This interaction seems to promote sperm
viability and be essential for sperm capacitation (Kervancioglu et al., 1994;
Murray and Smith, 1997; Kervancioglu et al., 2000). Many urinogenital
pathogens, such as Neisseria gonorrhoea and Chlamydia trachomatis
specifically attack the oviductal epithelium and severely disturb the ciliary
function (Lyons et al., 2006b).
   Oviductal CBF has been studied quite extensively, and the results have
revealed that progesterone markedly decreases oviductal ciliary beat.
Estradiol alone has no effect on CBF, though it can prevent the
progesterone-induced CBF reduction (Mahmood et al., 1998). Factors
increasing oviductal CBF include prostaglandins (Verdugo et al., 1980),
A B
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angiotensin II (Saridogan et al., 1996), follicular fluid and secretory phase
peritoneal fluid (Lyons et al., 2006a). The increase in oviductal CBF
evoked by prostaglandin E2 is mediated via the release of intracellular Ca2+
(Verdugo, 1980).
2.4.2.3 Respiratory cilia
   Respiratory cilia beat in a coordinated manner at 10-13 Hz (Chilvers et
al., 2003) and their role is to clear mucus and debris from the airways. This
is accomplished by the characteristic beat pattern with the power stroke
forward and the recovery stroke backward within the same plane (Chilvers
and O'Callaghan, 2000). Apart from its beat pattern, respiratory cilia differ
from ependymal and oviductal cilia in their smaller, 6 µm-size (Afzelius,
2004).
   The function of the respiratory ciliary cells has been a focus of many
studies. The mechanisms for regulation of ciliary amplitude is via direct
Ca2+ binding on inner dynein arm (Guerra et al., 2003). CBF regulation has
been proposed to follow cAMP-dependent activation of axonemal PKA,
which evokes dynein phosphorylation, ciliary bending and a CBF increase
(Salathe, 2007). Tracheal CBF has been reported to increase not only via
activation of PKA pathway by cAMP, but also via activation of
purinoceptors by ATP (Di Benedetto et al., 1991; Morse et al., 2001). It is
noteworthy that the regulation of ciliary function in different ciliated
tissues is divergent and even the same pathways may cause opposite effects
on CBF. For instance, ATP and cAMP which increase tracheal CBF, are
associated with a decline in CBF in ependymal cilia (Nguyen et al., 2001).
   Ineffective tracheal ciliary movement results in reduced mucociliary
clearance and thus, recurrent respiratory infections. In PCD, the patients
suffer from frequent sinusitis, otitis, cough and even asthma. Infections
may eventually lead to bronchiectasis (Chilvers and O'Callaghan, 2000;
Chodhari et al., 2004).
   Due to critical localization of tracheal cilia in terms of host defence,
acquired cilia disorders are not uncommon. Ciliary dysfunction may be
caused by various pathogens, such as Bordetella pertussis, Bordetella
bronchiseptica, Pseudomonas aeruginosa, or Mycoplasma pneumoniae.
Interference with axonemal Ca2+ movements has been proposed as a
mechanism by which pathogens can cause ciliary dyskinesia. Additionally,
gaseous irritant chemicals may directly damage the cilia (Afzelius, 2004).
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2.4.2.4 Nodal cilia
   During the time of early embryonic development, ciliary function plays a
critical role in left-right axis determination. Around the time of
gastrulation, the embryo develops a node which bears motile cilia. Nodal
cilia create a leftward flow of embryonic fluid in the node region, and thus
allow development of normal body situs. Nodal cilia lack the central
microtubule pair (9+0 structure) but do have dynein arms. As a result, the
motility is limited to a circular beating pattern. The exact mechanism to
account for the left-right asymmetry determination still remains unclear,
but mechanosensory and chemosensory pathways are presumably involved
(Afzelius, 2004; Satir and Christensen, 2007). Ciliary defects may result in
random left-right localization of organs, leading to situs inversus (Figure
6). The condition can be partial or complete (situs inversus totalis). In
humans, situs inversus is a common feature among PCD patients (Afzelius,
2004; Chodhari et al., 2004).
Figure 6. Nodal ciliary beat is required for left-right axis determination. Functional
nodal cilia create a leftward flow and ensure normal body situs (left). Nodal ciliary
dysfunction results in randomization of organ localization, situs inversus (right).
Reprinted from Ibañez-Tallon et al. (2003) with permission from Oxford University
Press.
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3 AIMS OF THE STUDY
The present study aimed to clarify the physiological role of Gai2 in
different ciliated tissues and to uncover the mechanisms controlling
ependymal ciliary function. The specific aims were as follows:
1. To administer in vivo antisense oligonucleotides to silence
Gai2 protein in rat brain ependymal cells, and thus to evaluate
the role of Gai2 in rat brain physiology.
2. To further clarify factors, such as the Gs-AC-cAMP-PKA
pathway, in the regulation of ciliary beat in rat brain
ependymal cells.
3. To clarify the presence and localization of Gai2 in the human
female reproductive tract and to evaluate the expression of
Gai2 during the menstrual cycle in the human endometrium.
4. To study the individual roles of estradiol and progesterone in
hormonal regulation of Gai2 in immortalised human oviductal
epithelial cells.
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4 MATERIALS AND METHODS
4.1 In vivo antisense study (I)
4.1.1 Experimental design
   This study aimed to knock down Gai2 protein by continuous in vivo
antisense oligonucleotide administration and to thus clarify the
physiological role of Gai2 in rat brain in vivo. The potential behavioral
responses were evaluated using selected behavioral tests.
   As the preliminary studies showed that the rats developed unilateral
ventricular dilatation of the infusion side, the next aim was to study this
phenomenon further and follow the development of ventricular dilatation
using magnetic resonance imaging in vivo. To confirm the knockdown of
Gai2 protein, histological analysis of brain sections was performed.
Western blot was used to evaluate any effects of AS treatment in the brain
areas adjacent to ventricles.
4.1.2 In vivo antisense oligonucleotide administration
4.1.2.1 Ethical aspects
   For in vivo antisense administration, three weeks old male Harlan Wistar
rats were used in accordance with the European Communities Council
Directive (86/609/EEC) and following a protocol approved by the local
ethics committee. In studies with adult animals, male Wistar rats (250g)
were used. The rats were bred in National Laboratory Animal Center,
University of Kuopio, and by National Public Health Institute, Kuopio, and
housed five per cage in 12-h light / 12-h dark cycle (lights on at 07:00 h)
with food and water ad libitum.
4.1.2.2 Oligonucleotides
   Unmodified 18-mer oligonucleotide sequences were chosen based on a
GenBank database search.  The sequence against Gai2 (5'-CTT GTC GAT
CAT CTT AGA-3') matched rat N-terminal sequence of Gai2 (nucleotides
150-167). The selected nonsense (5'-GGG GGA AGT AGG TCT TGG-3')
and mismatch (5'-TCT GCT GAT ACT CTT GAA-3') sequences did not
match any rat sequence.
   Oligonucleotides (Sigma-Genosys, Haverhill, UK) were high
performance liquid chromatography-purified (purity 90-97 %) and were
dissolved in sterile saline prior to use under RNase-free, aseptic conditions.
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4.1.2.3 Stereotaxic surgery
   After an adaptation period of three days, the animals were assigned to
three groups (saline control, AS-ODN and ODN control) and the brain
infusion cannulas were placed in the right lateral ventricles under chloral
hydrate (Merck, Darmstadt, Germany) anesthesia (350 mg/kg i.p.) using
stereotaxic surgery. Anatomical structures were identified based on Rat
Brain Atlas (Paxinos and Watson, 1998).
   Cannulas were fixed in the skull with metal or nylon screws (Plastics
One, Roanoke, VA) and dental cement (Voco, Cuxhaven, Germany). The
Alzet minipumps (Models 1007D and 2002, Durect, Cupertino, CA) were
placed subcutaneously dorsally, and after the procedure, the rats were
housed one per cage to prevent damage to the wounds and tubing. Animals
received saline (n = 22), antisense (n = 27), nonsense (n = 17) or mismatch
(n = 5) oligonucleotides as continuous i.c.v. infusion for 7 days (25 mg/day)
starting from surgery (days 24-31). Animals were examined and weighed
daily to ensure their health and growth. The same procedures were used
with the adult rats (250 g, total n = 5).
4.1.3 Behavioral studies
   On the 7th day of continuous i.c.v. infusion, animals (n = 8 per group)
were tested for motor coordination, anxiety, motor activity as well as for
pain perception and morphine-induced analgesia. The rota-rod test was
used to evaluate motor coordination, and the ability of rats to stay for 1 min
on a revolving rod (2 rpm) was examined. Elevated plus maze measured
anxiety and consisted of a plus-shaped maze with two open and two
enclosed arms. The rats were individually placed into the maze for 3 min
and their movements and the time spent in all of the arms were determined.
Normally, rats prefer the enclosed arms but show interest to enter also the
open arms. Anxious animals tend to remain in the enclosed arms. The open
field test was used to measure motor activity and consisted of a circular
maze with radial and circular lines marked on the floor. The rats were
individually placed into the maze and the line crossings were observed for
2 min. Tail immersion test was used to evaluate pain perception and
morphine analgesia. The outermost 4 cm portion of the rat tail tip was
immersed in +53 °C water bath 28 minutes after s.c. morphine injection (10
mg/kg), and the reaction time of tail withdrawal was measured. The test
was terminated after 15 s if the rat gave no response to the stimulus.
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4.1.4 Magnetic resonance imaging (MRI)
   Animals from saline control, ODN control (mismatch oligonucleotide),
and AS-ODN groups (n = 5 per group) were examined by high resolution
magnetic resonance imaging (MRI) to assess the status of the lateral, 3rd
and 4th ventricles in vivo. Rats were anesthetized with chloral hydrate (350
mg/kg i.p.), immobilized, and externally fixed to a custom-built animal
holder. To maintain normal body temperature, heated air was blown
through the magnet bore during the study. MRI was performed on the same
animals immediately before implantation of infusion cannulas (day 0) as
well as on days 2 (antisense rats only), 4, and 7 during the continuous i.c.v.
infusion.
   MRI was performed using A SMIS console (Surrey Medical Imaging
Systems, Guildford, UK) as detailed in I. Brain ventricle volumes (ml) and
ventricle wall surface areas (mm2) were calculated from consecutive
images by the Cavalieri principle (Roberts et al., 1993).
4.1.5 Histological studies on rat brain sections
4.1.5.1  Preparation of brain sections
   On the 7th day of continuous i.c.v. infusion, the rats (n = 8 per group)
were decapitated and the whole brains were dissected out, dipped in
isopentane on dry ice and stored at -80 °C. Serial coronal 20 mm-sections,
spanning Bregma 1.2 mm to -1.8 mm (Paxinos and Watson, 1998) were cut
at -20 °C using a Reichert-Jung cryostat. Six coronal sections, each from an
individual animal and two from each treatment group, were collected per
slide and thaw-mounted onto Super-Frost*/Plus slides (Menzel-Gläser,
Braunschweig, Germany) at 20 °C. The sections were stored at -80°C.
4.1.5.2      Histology and immunohistochemistry
   Slides with brain sections were immunostained as described in detail in I.
Immunofluorescent slides were imaged using Nikon Eclipse-TE300
inverted microscope, (Nikon Corporation, Japan) with an Ultra VIEW laser
scanning confocal device (Perkin-Elmer, Life Sciences, Inc. Boston, MA)
using ×60 objective. Images were processed using Adobe Photoshop
(Adobe Systems, Mountain View, CA).
   Routine hematoxylin-eosin staining was used to identify possible
histological damage of the brain.
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4.1.6    Western blotting protocols
4.1.6.1 Preparation of samples for Western blotting
   Animals within each treatment group (n=9), were assigned in groups of
three to pool tissue for Western blotting. 1-mm coronal slice from frozen
brains (Bregma 1.00 – 0.00 mm) were cut and two 1-mm diameter punches
were taken from each slice, both from left and right frontal motor cortex
(mCtx) and striatum (Str) (Paxinos and Watson, 1998). In order to dissect
out the choroid plexi (ChP) from both lateral ventricles, the rest of the brain
was thawed in an ice-water bath. Pooled tissues were sonicated in
sonication buffer (1 mM EDTA, 20 mM Tris-HCl pH 7.5) for 5 × 1 sec
(mCtx, Str) or for 10 × 1 sec (ChP) in an ice-water bath. The protein
content of the sonicates was determined using the bicinchoninic acid
(BCA) protein assay by Pierce Biotechnology (Rockford, IL).
4.1.6.2        Western blotting
   The pooled sonicates from mCtx, Str and ChP in all treatment groups
were processed as duplicates in Western blot (described in detail in I). Rat
forebrain punch sonicate was used as an internal standard. The films were
scanned using HP Precision Scan Pro and the band densities were
quantified in proportion to the densities of b-actin and internal standard
bands by using Scion Image software (Scion Corporation, Fredrick, MD).
4.2 Ciliary beat studies on rat brain ependymal cell culture (I,
II)
4.2.1 Experimental design
   Rat brain primary ependymal cell cultures were used to study ciliary beat
frequency (I, II) and amplitude (II). In order to clarify the potential
mechanism of the development of ventricular dilatation observed in in vivo
antisense study, the effect of antisense oligonucleotide administration on
CBF in vitro was evaluated (I). To further reveal the mechanisms
regulating ependymal ciliary beat in rats, a separate study was performed
(II). Ependymal cell cultures were treated with pituitary adenylate cyclase-
activating polypeptide (PACAP27) and adenylyl cyclase toxin (ACT) and
the changes in ependymal ciliary beat frequency and amplitude were
determined.
   Ciliary beat was recorded using a high speed video camera. CBF and
amplitude were determined from the captured video sequences.
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4.2.2 Establishment and maintenance of ependymal cell culture
   Rat brain ependymal cells were grown using a method adapted from
Weibel and colleagues (Weibel et al., 1986; Hirst et al., 2000). New-born
(younger than 24 hours old) Wistar rats were bred by Biomedical Services,
University of Leicester (UK). Dissociated tissue from a single brain was
seeded into eight well (25 × 35mm) tissue culture trays, 500 ml per well and
each well containing 2 ml of medium. The medium was replaced 3 days
after seeding. The complete growth medium was serum-free Minimum
Essential Medium (Invitrogen, Paisley, Scotland) containing penicillin (100
IU/ml), streptomycin (100 mg/ml), fungizone (2.5 mg/ml), bovine serum
albumin (5 mg/ml), insulin (5 mg/ml), transferrin (10 mg/ml), selenium (5
mg/ml).
   The adherent ependymal cells were maintained by the replacement of 2
ml of fresh medium three times a week. The ciliated ependymal cell
colonies were identified at day 5 and experiments were conducted using
cells that were between 14-28 days old, a time when cell proliferation was
optimal.
4.2.3 Experimental setting for ciliary beat recording
   To determine ciliary beat frequency the cells were placed in a humidified
(70-90 %) incubation (37 oC) chamber and observed using an inverted
microscope system (Diphot, Nikon). Beating cilia were recorded using a
digital high-speed video camera (Kodak Ektapro Motion Analyser, Model
1012 or Troubleshooter, Lake Image Systems), rate 400 or 500 frames per
second, shutter speed of 1/ 2000 s.
   The camera allows video sequences to be recorded and played back at
reduced frame rates or as frame-by-frame. Ciliary beat frequency was
determined by timing a given number of individual cilia beat cycles. Basal
ciliary beat frequency was measured at 0 minutes, before addition of
oligonucleotides, pneumolysin or other compounds. Calculation of CBF:
frequency (Hz) = [ Number of frames recorded per second / frames elapsed
for 5 ciliary beat cycles ] × 5 (conversion per beat cycle).
   Ciliary amplitude was determined using the captured video sequences.
The distance between the outermost points that the individual cilia tip
reached were measured.
4.2.4 Compound addition
   All experiments with oligonucleotides were performed in 1 ml of filter
sterilised (0.2 µm, acrodisc) artifical cerebrospinal fluid [aCSF (mM): NaCl
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(128), KCl (3), CaCl2 (1.3), MgCl2 (1), NaH2PO4 (22.3), D-Glucose (1.25)
in deionised water pH 7.4 with 10M NaOH]. Pneumolysin, which has
previously been shown to inhibit CBF in ependymal cultures (Hirst et al.,
2000), was purified as previously described (Mitchell et al., 1989), made up
in aCSF at 500 Haemolytic Units (HU)/ml and used as a positive control
for inhibition of ependymal ciliary beat frequency (CBF). Negative
controls were incubated in 1 ml of aCSF alone. AS-ODN and ODN control
oligonucleotides diluted to 122 mM with 1 ml of aCSF and then added to
the cells. The cells were incubated at (37 oC) for 8 hours with CBF readings
taken at 0, 1, 3, 6 and 8 hours. At 8 hours, aCSF was exchanged for 1 ml of
complete growth medium and incubated at 37 oC for 48 hours with CBF
readings taken at 24, 27, 30 and 48 hours.
   All experiments with PACAP27 and ACT were performed in Hepes-
buffered minimum essential media (MEM) without additives. PACAP27
(Tocris, Bristol, UK), in active peptide antagonist of PACAP (PACAP 6-
27) (Sigma-Aldrich) and ACT (Sigma-Aldrich) were diluted to their final
concentrations in 1 ml MEM. Negative controls were incubated in 1 ml of
MEM alone.
4.3 Gai2 in human reproductive tract (III) and OE-E6/E7 cell
line (IV)
4.3.1 Experimental design (III, IV)
   Expression of Gai2 gene in human female reproductive tract was studied
using complementary DNA (cDNA) derived from human tissue samples
and cultured cells (III). Human endometrial and Fallopian tube tissue were
collected and used for cDNA synthesis. Fallopian tube tissue was also used
for the establishment of primary cell culture of luminal epithelial cells. The
resulting primary epithelial cell culture was used for cDNA synthesis. A
detailed analysis of Gai2 expression during the menstrual cycle was
performed using cDNA derived from endometrial biopsies spanning the
menstrual cycle. Localization of Gai2 in endometrial and Fallopian tube
tissues was studied by immunohistochemistry using tissue sections.
   An immortalized human oviduct epithelial cell line (OE-E6/E7) was used
to study the expression of different signalling components (IV). In order to
clarify the effects of sex hormones on gene expression, the OE-E6/E7 cell
line was firstly cultured with different concentrations of estradiol or
progesterone for 5 days. Quantitative real-time PCR was then performed
using the cDNA of the hormone treated cells.
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4.3.2 Human tissue samples (III)
4.3.2.1 Ethical aspects and tissue collection
   This study was approved by the Local Ethics Committee in The
University of Sheffield (UK). Informed written consent was obtained prior
to the collection of tissue samples. All the women taking part in the
investigation had regular cycles, showed no evidence of any pathological
uterine disorder, and had not used oral contraception or an intrauterine
device during the previous three months.
   Endometrial biopsies were obtained from voluntary women with proven
fertility (each had had at least one previous successful pregnancy). The
mean age of the women taking part in the study was 35 (range 24-40)
years. Biopsies were collected between 2 and 29 days after the last
menstrual period (LMP). For genomic studies, biopsies were obtained from
21 women and for immunohistochemical investigations from 6 women.
Human Fallopian tube tissue samples were collected from 9 patients
undergoing total abdominal hysterectomy for benign gynaecological
conditions. The mean age of the women taking part in the study was 42
(range 33-56) years.
4.3.2.2 Preparation of endometrial tissue samples
   Endometrial biopsies were collected in the operating theatre. For genomic
studies, biopsies were immediately placed in RNAlater (Ambion,
Huntingdon, UK), stored for 24 hours at 4 °C and immersed and stored in
liquid nitrogen until processed. Endometrial biopsies for
immunohistochemistry were immediately snap-frozen and stored in liquid
nitrogen until processed. Cryosections were cut at 5 µm and stored at -70
°C until use.
4.3.2.3 Preparation of Fallopian tube tissue samples
   Human Fallopian tube tissues were collected in the operating theatre.
Tissue samples for genomic studies were immediately placed in RNAlater
(Ambion), and stored for 24 hours at 4 °C followed by immersion and
storage in liquid nitrogen until processed. Tissue samples for
immunohistochemistry were immediately fixed in 10 % formalin overnight
and embedded in paraffin. Paraffin sections were cut at 5 µm.
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4.3.2.4 Establishment and maintenance of Fallopian tube epithelial
cell culture
   Fallopian tube tissue samples for primary epithelial cell cultures were
collected in the operating theatre. Luminal epithelial cells were extracted as
described in III.
   Fallopian tube primary epithelial cells were cultured at +37 °C in DMEM
(F12) culture media (Invitrogen) supplemented with 1 % penicillin and
streptomycin (Sigma-Aldrich), 10 % fetal calf serum (Invitrogen) and L-
glutamine (Invitrogen) in 5 % CO2 atmosphere.
4.3.3 Cell culture of OE-E6/E7 cell line (IV)
   For maintenance, an immortalised human oviduct epithelial cell line OE-
E6/E7 (Lee et al., 2001) was cultured in DMEM (F12) culture media
(Invitrogen) supplemented with 1 % penicillin and streptomycin (Sigma-
Aldrich), 10 % fetal calf serum (Invitrogen) and L-glutamine (Invitrogen),
at +37 °C in 5% CO2 atmosphere.
   In hormone treatment studies, OE-E6/E7 cells were cultured in triplicates
at +37 °C in DMEM (F12) culture media without serum and phenol red
(Invitrogen), supplemented with 1% penicillin and streptomycin (Sigma-
Aldrich). Water-soluble estradiol (Sigma-Aldrich) was used at 0.1 nM, 1
nM, 10 nM and 100 nM concentrations. Water-soluble progesterone
(Sigma-Aldrich) was used at concentrations of 1 nM, 10 nM, 100 nM and
1000 nM. In both experiments, control media was supplemented with
cyclodextrin (Sigma-Aldrich). The cells were split into hormone media and
cultured until confluency (for 5 days).
4.3.4. Genomic studies (III, IV)
4.3.4.1 Primers
   Primer pairs from Metabion (Martinsried, Germany) were used. The
amplified sequences, products sizes and annealing temperatures used are
described in detail in Table 2. All primers were designed for this study
except for the primer pairs for the membrane progesterone receptors mPRa
and mPRb, which have been described earlier (Karteris et al., 2006).
4.3.4.2 RNA isolation, purification and cDNA synthesis
   The collected reproductive tissues were homogenised as described in III.
Total RNA was extracted from tissues and cultured cells and purified as
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detailed in III and IV. Negative controls (RT controls) were prepared
without the enzyme and thus were not reverse transcribed.
Table 2. Primer pair details for the genomic studies (II-III).
Target Product
size
(bps)
Forward 5’-3’ Reverse 5’-3’ Annealing
temp (°C)
b-Actin 643 TGA CCC AGA TCA TGT TTG AGA CC GGA GGA GCA ATG ATC TTG ATC TTC 58
Gai2 212 CTT GTC TGA GAT GCT GGT AAT GG CTC CCT GTA AAC ATT TGG ACT TG 65
ERa 288 GAA TCT GCC AAG GAG ACT CG ATC TCT CTG GCG CTT GTG TT 64
ERb 217 CCA GCA ATG TCA CTA ACT TGG A TTC CCA CTA ACC TTC CTT TTC A 57
PR-A,B 221 GGA GAA CTC CCC GAG TTA GG AGG GAG GAG AAA GTG GGT GT 61
PR-B 232 GAC TGA GCT GAA GGC AAA GG CTG CTG GTC CTG CGT CTT TT 61
mPRa 200 GCG GCC CTG GTA CTG CTG C CAC GGC CAC CCC CAC A 65
mPRb 289 GCT GTT CAC TCA CAT CCC TGG TGC AAC CCC CAG A 65
4.3.4.3 Polymerase Chain Reaction
   Polymerase chain reaction (PCR) was performed using the constructed
cDNAs, Platinum Blue PCR Super Mix (Invitrogen) and primers from
Metabion (Table 2). The amplification was run for 35-40 cycles under the
following conditions: 95 °C 30 sec (denaturation), annealing temperature
for each primer 30 sec, 72 °C 30 sec (elongation). All experiments included
RT controls and negative controls (no cDNA). PCR products were
separated on 1.2 % agarose gel.
4.3.4.4 Quantitative real time polymerase chain reaction
   Quantitative real time PCR (Q-PCR) was performed in triplicates using
the constructed cDNAs and the same primers (Table 2) that were used in
PCR reactions (method described in detail in III, IV).
   Q-PCR results were analyzed using iCycler (Biorad laboratories Ltd,
Hemel Hempstead, UK). To compare relative quantities of Gai2 expression
during the menstrual cycle (III), endometrial biopsies were divided into
three groups; menstrual (LMP + 1-4 ; n = 3; LMP +1, +4 and +4),
proliferative (LMP + 5-14 ; n = 9; early proliferative LMP +5, +5 and +7,
mid-proliferative LMP +8, +9 and +10, late proliferative LMP +11, +12
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and +13) and secretory (LMP + 15-29 ; n = 9; early secretory LMP +16,
+16 and +17, mid-secretory LMP +20, +21 and +22, late secretory LMP
+26, +28 and +29). Relative Gai2 expression quantities were compared
between these groups.
4.3.5 Immunohistochemistry on human endometrium and
Fallopian tube (III)
   The endometrial biopsy specimens were timed according to LMP and the
morphology was evaluated according to the Noyes criteria (Noyes, 1950)
so that they could be divided into three groups, menstrual, proliferative or
secretory.
   Endometrial cryosections and Fallopian tube paraffin sections were
immunostained using Vectastain Elite ABC Kit (Vector) according to the
manufacturer’s instructions (described in III). The slides were imaged
using a ×40 objective on an Olympus CKX41 microscope. Digital images
were captured with a Nikon Coolpix 5400 camera and processed using
Adobe Photoshop (Adobe Systems).
4.3.6 Western Blot Analysis (IV)
   OE-E6/E7 cells were lysed by sonication as described in IV, and the
protein content was measured using BCA protein assay by Pierce.
Sonicates (50 mg protein / lane) were resolved in 10 % Sodium-dodecyl
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and blotted onto
PVDF membrane (0.2 mM, Millipore Corporation, Billerica, MA). The
chemiluminescent reaction was started with Western Lightning ECL
substrate (Perkin-Elmer). The signal was detected on Hyperfilm ECL (GE
Healthcare UK Ltd, Buckinghamshire, UK). The films were scanned using
ImageScanner (GE Healthcare).
4.4 Statistical analysis (I-IV)
   MRI results are presented as mean ± SEM. Ciliary beat frequency and
amplitude data are presented as mean ± SEM of individual CBF or
amplitude measurements from 4-11 separate cell cultures. The mean
reading of each individual culture was obtained from 5 randomly chosen
cilia. In genomic studies, the threshold cycle values of samples were
normalised against a threshold value of human b-actin. The results are
expressed as mean ± SEM.
   Statistical comparison was performed either by using one-way analysis of
variance with Tukey's multiple comparison test (I-IV), or by student’s
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unpaired, two-tailed t-test (IV), analyzed with GraphPad Prism for
Windows (GraphPad Software, Inc., San Diego, CA). Statistical
significance was achieved when p<0.05.
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5 RESULTS AND DISCUSSION
5.1 In vivo antisense study (I)
5.1.1 Magnetic Resonance Imaging
   During the 7 days of i.c.v. AS-ODN treatment, the rats developed
unilateral ventricular dilatation that was restricted to the AS-ODN-
receiving lateral ventricle (I, Figure 1). A detailed high resolution magnetic
resonance imaging (MRI) analysis revealed a supratentorially restricted
enlargement, but no signs of subarachnoidal enlargement indicative of
brain atrophy. There were no signs of asymmetry attributable to obstruction
in the ventricular system, beyond the ipsilateral ventricle on MRI. Neither
saline nor control ODN infusion evoked a similar effect. Since juvenile 3-5
weeks old rats (50-100 g) were used, the experiment was repeated for
confirmation in adult animals but the outcome was the same.
   The time-course of ventricular dilatation development was examined by
high resolution MRI in vivo. The status of the ventricular system in all
animal groups was assessed by MRI both prior to cannula implantation on
day 0, and during the i.c.v. infusion on days 2, 4, 7 (I, Figures 1, 3).
Ventricular volumes (ml) and wall surface areas (mm2) were calculated
from consecutive MRI images using the Cavalieri principle (Roberts et al.,
1993). In AS-ODN treated rats, the ipsilateral ventricles dilated
dramatically with the dilatation reaching a plateau on day 4. The volume
increase of the ipsilateral ventricle was statistically significant (p<0.001)
already on day 2, while the volumes of contralateral, 3rd and 4th ventricles
remained constant, equal to that measured on day 0. Similarly, the surface
area of the ipsilateral ventricle wall enlarged extensively, being
significantly larger (p<0.001) from day 2, while the surface areas of the
contralateral, 3rd and 4th ventricles showed no significant changes in
comparison to day 0. No changes were seen in either ventricular volume or
in the ventricular wall surface area in ODN or saline control animals.
   In order to clarify whether the ventricular dilatation was reversible upon
cessation of AS-ODN infusion, the time-response relationship of 2-day
i.c.v. Treatment with AS-ODN followed by a 9-day i.c.v. saline infusion
was studied. The results showed that the AS-ODN-evoked ventricular
dilatation was not reversible during the 11-day observation period (I,
Figure 4). This outcome was expected, as in mammalian ependymal cells,
there is no evidence of regeneration at any age (Sarnat, 1995; Bruni, 1998).
Although a regenerative response of subependymal cells following brain
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trauma has been reported (Chen et al., 2003), proliferation markers, such as
Ki-67, have not been found in the ependyma even in fetal life (Coons et al.,
1989; Cattoretti et al., 1992). Even if slow regeneration of the ependymal
cells could occur in the long run, those responses would not have been
relevant during the 9-day time window of this study.
5.1.2 Histological studies on rat brain sections
   The histological status of lateral ventricles was studied in all animal
groups by using hematoxylin-eosin staining on rat brain cryosections. The
staining was conducted for 8 animals in each group, and one representative
specimen from each treatment group was selected to visualize the general,
light microscopic view of the lateral ventricles (I, Figure 5). The
ependymal cell layer of ODN and saline control groups showed a normal,
uniform ependymal cell row with numerous cilia, but the structure of the
ipsilateral ependymal cell layer in AS-ODN treated animals appeared
damaged, irregular and ruptured, with practically no cilia present.
Additionally, the ipsilateral ventricle of AS-ODN treated animals displayed
numerous dying cell populations within the ventricular cavity, potentially
damaged ependymal cells. This outcome is in line with previous studies,
since the characteristic ependymal changes following either acute or
chronic hydrocephalus, are decreased cilia density and a discontinuous,
stretched and torn ependymal layer (Page et al., 1979; Bannister and
Chapman, 1980; Sarnat, 1995; Kiefer et al., 1998).
   The knockdown of Gai2 protein in ependymal layer was verified by
immunohistochemistry. Two different primary antibodies were used,
namely, a previously validated, polyclonal affinity-purified reference
antibody (Asano et al., 1989) and a commercially available monoclonal
antibody (Chemicon), which had not been previously validated for use in
immunohistochemistry. Gai2 immunolabeling in ependymal cells and cilia
by the two primary antibodies was imaged by confocal microscopy (I,
Figure 7). Both antibodies showed specific and restricted labeling of Gai2
in the ependymal cells and cilia. Though there were some minor
differences, the final outcome was the same with both antibodies. AS-ODN
treated animals demonstrated a loss of ependymal cilia and an attenuation
of Gai2 protein, whereas Gai2 immunostaining in ODN and saline control
groups was identical with both antibodies. While the polyclonal reference
antibody (Asano et al., 1989) interacted solely with ependymal cilia,
Chemicon's monoclonal antibody specifically recognized cilia and also
labeled structures surrounding the ependymal cell nucleus. The slight
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difference between the intracellular immunostaining with these antibodies
could be due to their different target regions in the Gai2 protein and/or due
to potential cross-reactivity of the commercial antibody with additional
targets.
5.1.3 Western blot analysis
   We performed semi-quantitative Western blotting of selected brain
structures to examine the extent of the AS-ODN effect in close vicinity to
the lateral ventricles. No penetration of AS-ODN into the adjacent neural
structures was seen in this study, as the immunoreactivity of Gai2 protein in
areas distant from lateral ventricles, such as motor cortex and striatum did
not reveal any significant changes between the animal groups (I, Figure 8).
5.1.4 Behavioral studies
   During the 7-day infusion period, the animals did not show any abnormal
behaviour and grew normally (I, Figure 2). Young, 3-5 week old male rats
were used, but ventricular dilatation was seen after a 7-day i.c.v. AS-ODN
treatment also in adult animals. Gai2 protein levels in rat brain are high
already at birth, and increase slightly until the age of 90 days (Ihnatovych
et al., 2002). As the structure of the ependymal layer reaches maturity by
the age of 1-3 weeks, and the cilia are fully developed by the first postnatal
week in mice and rabbits (Tennyson and Pappas, 1962; Bruni, 1998;
Spassky et al., 2005), young animals instead of adults were used
throughout the in vivo antisense study.
   There were no signs of colitis or immunological abnormalities which
have previously been reported in Gai2 knockout animals (Rudolph et al.,
1995a; Rudolph et al., 1995b). However, dehydration was invariably
evident from day 2 onwards. In line with this finding, dehydration has been
earlier reported in mice with infection following i.c.v.-delivered Bordetella
pertussis pathogen (Berenbaum et al., 1960). Potentially, the
circumventricular organs (CVOs) bordering the 3rd and 4th ventricle,
might be under neuroendocrine regulation by compounds present in the
circulating CSF (Strazielle and Ghersi-Egea, 2000). Apparently, i.c.v.
administered AS-ODNs can readily reach CVOs and thus, might easily
interfere with the signalling pathways regulating body fluid homeostasis.
Previous studies have demonstrated that i.c.v. AS-ODN treatment can
effectively reach CVO cells, as in vivo i.c.v. administration of an AS-ODN
targeted against the angiotensin AT1 receptor resulted in thirst attenuation
in rats (Sakai et al., 1995).
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   Behavioral tests for motor coordination, anxiety, motor activity as well as
for pain perception and morphine analgesia revealed no significant
differences between the groups (results not shown).
5.2 Ciliary beat studies on rat brain ependymal cell culture (I,
II)
5.2.1 CBF experiments of in vivo antisense study (I)
   CBF measurements on cultured rat ependymal cells were carried out to
evaluate whether there was direct effect of AS-ODN on ciliary function.
The present study revealed that AS-ODN administration resulted in
decreased CBF, leading to irreversible ciliary stasis (I, Figure 9). In
contrast, the control oligonucleotide had no effect on the regulation of
ciliary function. This data provide evidence of ciliary inhibition as an
explaining factor in the development of ventricular dilatation in AS-ODN
rats in vivo. The role of ependymal ciliary beat in CSF flow direction is
well established (Cathcart and Worthington, 1964; Yamadori and Nara,
1979) and the connection between ciliary function and CSF homeostasis
has been clearly demonstrated. Namely, ciliary dysfunction or immotility
(Shimizu and Koto, 1992; Nakamura and Sato, 1993) as well as defects in
ciliary structure components (Ibañez-Tallon et al., 2002; Sapiro et al.,
2002; Ibañez-Tallon et al., 2004) or defects in proteins involved in
ciliogenesis (Chen et al., 1998; Taulman et al., 2001; Kobayashi et al.,
2002) all result in hydrocephalus. Further, PCD, which has the etiology of
either inefficient ciliary function or immotile cilia, is associated with
various cilia-related symptoms, frequently including hydrocephalus
(Chodhari et al., 2004). In addition to the apparent causality between ciliary
inhibition and hydrocephalus, loss of normal ciliary function in ChP in vivo
has been shown to cause disturbed cAMP-regulated chloride transport,
leading to excess CSF production and hydrocephalus (Banizs et al., 2005).
   In comparison to the direct toxic effects on beating cilia evoked by the
positive control pneumolysin (Mohammed et al., 1999; Hirst et al., 2000),
the effect observed after AS-ODN administration emerged gradually after a
delay. This delay might reflect the time needed for AS-ODN to enter the
cells and to terminate the synthesis of its target protein Gai2. Furthermore,
the delay might be explained by time needed for Gai2 turnover. Statistical
analysis showed that CBF of AS-ODN treated cells differed significantly
(p<0.001) from CBF in ODN and saline control groups since the timepoint
of 6 hours.
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   The morphology of cultured ependymal cells treated with AS-ODN
appeared normal at the timepoint when ciliary stasis occurred (8 hours).
However, during the 48-hour observation period, the cells gradually started
exhibiting decreased viability. In contrast, cells treated with pneumolysin
typically died immediately after the exposure, due to the acute
inflammation response.
   In addition to this study, there is earlier evidence that inactivation of Gi
family proteins is associated with hydrocephalus. Namely, mice with i.c.v.
infection by Bordetella pertussis have been reported to develop
hydrocephalus (Berenbaum et al., 1960; Hopewell et al., 1972). Moreover,
previous studies with cultured hamster tracheal tissues have shown that
Bordetella pertussis infection results in ciliary stasis (Collier et al., 1977;
Muse et al., 1977). Since pertussis toxin induces hydrocephalus following
an interaction with the ependymal cilia, and causes whooping cough due to
its effects on the respiratory cilia, it seems clear that the Gi family proteins
have a fundamental role in ciliary function. A cilia-related role for G?i2 is
further supported by the fact that it is the predominant Gi protein present in
mammalian ependymal cilia, as well as in motile cilia in different
peripheral tissues, such as rat oviduct and trachea (Shinohara et al., 1998;
Ostrowski et al., 2002).
   Even though the present data suggest that the ventricular dilatation
observed following AS-ODN treatment could be attributable to ciliary
stasis, other potential contributing factors cannot be totally excluded. For
instance, knockdown of G?i2 in the choroid plexus might have also been
involved in the disturbed CSF homeostasis and ventricular dilatation. There
is previous evidence of intracellular cAMP levels positively regulating CSF
production in the choroid plexus (Saito and Wright, 1983). Furthermore,
elevated PKA or PKC activity might be involved in the development of
hydrocephalus, as suggested from results of a study on mice overexpressing
PAC1 receptor (Lang et al., 2006). There is also the possibility that
knockdown of G?i2 in the choroid plexus and the consequent excess cAMP
activity, could then lead to disturbed cAMP-regulated chloride transport
and excess CSF production, due to the proposed linkage between ciliary
dysfunction and the development of hydrocephalus (Banizs et al., 2005).
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5.2.2 CBF and amplitude experiments with PACAP27 and ACT
(II)
   Pituitary adenylate cyclase-activating polypeptide (PACAP) is a
pleiotropic polypeptide, which can exist in two forms, PACAP38 and
PACAP27 (Miyata et al., 1989; Miyata et al., 1990). Both forms are
equipotent in their ability to activate the Gs-AC-cAMP-PKA pathway, but
only PACAP38 can potently activate PLC via the PAC1 pathway (Spengler
et al., 1993; Basille et al., 1995). In the present study, PACAP27 was
selected in order to clarify the AC-stimulating effects of PACAP in the
regulation of ciliary function. The data revealed a significant decrease in
ciliary beat frequency and amplitude following PACAP27 treatment (II,
Figure 1). If the media was changed immediately after the experiment, the
inhibitory effect was reversible when examined after 24 hours (data not
shown). The role of neuropeptide PACAP in regulation of CSF
homeostasis is supported by the fact that patients with gene multiplications
in regions 18p11 and 7p15, where the genes for PACAP and for its receptor
PAC1 reside (Hosoya et al., 1992; Ogi et al., 1993), have been reported to
be at risk of suffering hydrocephalus (Miller et al., 1979; Takeda et al.,
1989). Similarly, mice overexpressing the PAC1 receptor have been
described as developing hydrocephalus (Lang et al., 2006).
   The peptide antagonist PACAP 6-27 was used in combination with
PACAP27 to clarify whether the PACAP27 effects on CBF and amplitude
were receptor-mediated, and both PACAP27 effects were inhibited by the
antagonist (II, Figure 2), whereas PACAP 6-27 administered alone did not
change CBF or amplitude (data not shown). PACAP functions are mediated
through three G protein-coupled receptors, PAC1, VPAC1 and VPAC2.
The inactive peptide PACAP 6-27 acts as an antagonist at PAC1 and
VPAC2 receptors, but not on VPAC1 (Harmar et al., 1998). Since the data
showed that PACAP27-induced inhibitory effects on ciliary function were
fully inhibited by PACAP 6-27, it seems evident that VPAC1 receptor does
not have any role in mediating the inhibition of ciliary function. An earlier
study on PAC1 overexpressing mice (Lang et al., 2006) strongly supports
involvement of PAC1 receptors in this response. There is autoradiographic
and immunohistochemical evidence of VPAC2 localization in ependyma
(Joo et al., 2004) and subventricular zone (Vertongen et al., 1997), which
suggests that the ciliary regulation observed here might in part be mediated
by VPAC2. However, VPAC2 localization in ventricle surrounding regions
is not supported by in situ hybridisation studies (Usdin et al., 1994;
Sheward et al., 1995; Basille et al., 2000). The ciliary regulation is possibly
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largely mediated by PAC1, but VPAC2 may also be involved. Naturally,
cell proliferation and expression of PACAP, PAC1 and VPAC2 in rat
primary ependymal cultures may differ from that encountered in vivo. The
cells used for primary cultures are derived from newborn rats, and there is
evidence that the PAC1 mRNA intensity in ventricular regions remains
high during the first postnatal week (Jaworski and Proctor, 2000).
Distribution of PAC1 and VPAC1 has been shown to be very similar in the
ventricular regions of the developing rat brain, whereas VPAC2 is present
in other areas during development (Basille et al., 2000).
   ACT treatment of the ependymal cells was used to mimic the elevation in
the intracellular level of cAMP following receptor stimulation by
PACAP27. ACT evoked a decrease in the amplitude, identically to
PACAP27, but during the 240min experiment it did not significantly
change CBF (II, Figure 3). Similarly, PACAP27 did not clearly inhibit
CBF at 240min, but between the 240-360min timepoint. The correlation
between ACT- and PACAP27-induced decreases in the amplitude was
significant (r2=0.9049, p<0.0001). Prior to this study, there was some
evidence that the AC-cAMP-PKA pathway is involved in inhibition of
ependymal ciliary function. Study I (Mönkkönen et al., 2007b), suggested
that disturbed AC activity caused by attenuation of Gai2 resulted in
ventricular dilatation in vivo and ciliary stasis in vitro. Furthermore,
forskolin treatment, which increases the levels of intracellular cAMP, has
been shown to decrease CBF (Nguyen et al., 2001). The present data are
the first evidence of ependymal ciliary amplitude regulation via the AC-
cAMP-PKA pathway. An earlier study with mice overexpressing PAC1
receptor is in line with these findings, as those mice had elevated PKA and
PKC activity, ciliary defects and increased apoptosis which were associated
with the development of hydrocephalus (Lang et al., 2006). The present
data on the involvement of AC-cAMP-PKA pathway in the inhibition of
ependymal ciliary amplitude provide an alternative explanation for reduced
CSF flow and the development of hydrocephalus in PAC1 overexpressing
mice.
   In spite of the many well conserved structural and functional features
between different ciliated tissues (Satir and Christensen, 2007), the
pathways regulating ciliary beat function do not seem to be identical in
different tissues. For instance, the AC-cAMP-PKA pathway, which is
strongly associated with CBF inhibition in the ependymal cilia (Nguyen et
al., 2001; Mönkkönen et al., 2007b), has been reported to increase tracheal
CBF  (Di  Benedetto et al., 1991;  Morse et al., 2001).  With  regard  to  the
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Figure 7. Potential factors involved in the regulation of ependymal ciliary beat and CSF
homeostasis. In the physiological situation (left), Gai2 maintains normal ciliary beat by
inhibiting AC-cAMP signalling pathways, by regulating intracellular Ca2+
concentration, or perhaps via additional mechanisms. The activity of Gai2 may be
regulated by neurotransmitters or modulators acting through cell surface G protein-
coupled receptors (GPCR) and/or through receptor-independent intracellular
mechanisms involving AGS proteins. AS-ODN knockdown of Gai2 (right) or its
inactivation by PTX results in ciliary stasis and hydrocephalus due to dysfunction of
Gai2-dependent signalling mechanisms. Alternatively, PACAP signalling may cause
ciliary stasis, or amplitude decrease, via Gs-AC-cAMP pathway. Dash arrows =
mechanism not available or availability limited.
molecular mechanisms of ciliary function, the outer dynein arms generally
account for ciliary beat frequency, while the inner dynein arms are
responsible for the amplitude (Brokaw and Kamiya, 1987; Satir et al.,
1995; Habermacher and Sale, 1997). In tracheal cilia, which have been in
focus of many studies, the underlying mechanism behind the CBF increase
has been proposed as cAMP-dependent activation of axonemal PKA,
which evokes dynein phosphorylation (Salathe, 2007). Furthermore, studies
on Tetrahymena have shown that ciliary amplitude changes via direct Ca2+
binding to inner dynein arm (Guerra et al., 2003). Potentially, the amplitude
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decrease observed in the present study by PACAP27 and ACT could be
explained by altered inner dynein arm activity, evoked by a cAMP-
dependent pathway.
   With respect to the situation of Gai2 signalling in the ependymal cilia,
there is very limited information available on its potential signalling
partners, namely GPCRs. To date, GPCRs have not been identified on the
ciliary membrane in any ciliated tissue. However, prior to the present
findings of PACAP receptor-mediated regulation of ependymal ciliary
function (II), there was some evidence that at least the function of
respiratory cilia could be regulated via P2Y purinergic receptors (Morse et
al., 2001). One important aspect of Gai2 signalling is the fact that classical
GPCRs are not necessary for its Gai2 activation. AGS proteins, such as
AGS2 which exist complexed with dynein in the cytoplasm, have been
demonstrated to activate Gai2 and other G proteins independently of
GPCRs (Blumer and Lanier, 2003).
   A summary of factors regulating ependymal ciliary function in the light
of present findings is presented on the schematic diagram (Figure 7).
5.3 Gai2 in human female reproductive tract (III) and OE-
E6/E7 cell line (IV)
5.3.1 Genomic studies on human endometrium and Fallopian
tube (III)
   The presence of Gi family proteins has been earlier studied in human
endometrium during artificial cycles of hormone replacement therapy
(Bernardini et al., 1995, 1999), but due to lack of a specific antibody able
to discriminate between the closely related Gai1 and Gai2, details of Gai2
protein have remained unclear. Now, PCR data on human Fallopian tube
tissue and human endometrial biopsies revealed that the Gai2 gene is
expressed in both tissues (III, Figure 1 A, B). The results also confirmed
the expression of the Gai2 gene in primary cultures of Fallopian tube
epithelial cells (III, Figure 1C).
   Further genomic analysis was performed using quantitative real time
PCR on endometrial biopsies spanning the menstrual cycle. The biopsies
were subdivided into three groups based on the phase of the menstrual
cycle of the patients, namely menstrual (last menstrual period, (LMP) + 1-
4), proliferative (LMP + 5-14) and secretory (LMP + 15-29). The results
showed that the expression of the Gai2 gene increased significantly during
the cycle, reaching its peak in the secretory phase. The expression of Gai2
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gene in the secretory phase was significantly higher (p < 0.05) compared to
that analysed in the other phases. Prior to this study, cyclical changes in
Gai2 expression had not been reported in humans. These data suggest that
the sex hormones, oestrogen and/or progesterone, might regulate the
expression of Gai2 in human endometrium. Earlier studies on rat
myometrium have revealed that estradiol administration during rat
pregnancy can increase the levels of both Gai2 and Gai2 mRNA, while
progesterone has no effect on Gai2 expression (Cohen-Tannoudji et al.,
1995).
   Control experiments with non-reverse transcribed RNA of each sample
confirmed that there was no contamination of human deoxyribonucleic acid
(DNA) in the samples.
5.3.2 Immunohistochemistry of human endometrium and
Fallopian tube (III)
   Immunostaining of Fallopian tube paraffin sections revealed that Gai2
protein was specifically localized in Fallopian tube epithelial cells and
enriched in the cilia (III, Figure 2 C). Additionally, positive
immunostaining was seen in the cytoplasm of epithelial cells, surrounding
the nuclei. In endometrial tissue, Gai2 staining was enriched in endometrial
glands, but was present also in stroma (III, Figure 2 A, B). Presumably, the
positive immunostaining surrounding the nuclei, represents pre-stage Gai2
which is still being synthesized, or alternatively, Gai2 which is ready for
transport into cilia by intraflagellar transport mechanisms (Rosenbaum and
Witman, 2002).
   This data revealed for the first time the localization of Gai2 in Fallopian
tube epithelial cilia. Apart from proteomic analysis which has provided
evidence of G?i2 as a resident axonemal protein in the human bronchial
cilia (Ostrowski et al., 2002), there are no reports describing G?i2 in human
ciliated tissues. Since Gai2 is specifically localized in different rat tissues
bearing motile cilia with their characteristic 9+2 ultrastructure, namely in
rat oviductal, tracheal and brain ependymal cilia (Shinohara et al., 1998), it
seems evident that Gai2 has a cilia-related physiological role. In Fallopian
tubes, ciliary beat is essential for gamete transport in association with the
tubal secretory flow and muscle contractility. Furthermore, Fallopian tubes
have been proposed to act as sperm reservoirs, where the ciliated epithelial
cells interact with sperm (Pacey et al., 1995a; Pacey et al., 1995b; Baillie et
al., 1997; Reeve et al., 2003). Fallopian tube epithelial cells have also been
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demonstrated to preserve the viability of sperm (Kervancioglu et al., 1994;
Murray and Smith, 1997; Kervancioglu et al., 2000).
5.3.3 Genomic studies and Western blot analysis on OE-E6/E7
cell line (IV)
   PCR studies on the OE-E6/E7 cell line confirmed that the Gai2 gene is
expressed in these cells (IV, Figure 1A). The presence of Gai2 protein in
OE-E6/E7 cells was verified by Western blot analysis, but the protein level
was relatively low (IV, Figure 1B).
   In order to evaluate the individual effects of steroid sex hormones,
estradiol and progesterone, on the expression of Gai2 gene, a hormone
treatment experiment on OE-E6/E7 cell line was carried out. Quantitative
real time PCR results showed that Gai2 gene was up-regulated by low
concentrations of estradiol (IV, Figure 2A), while progesterone did not
evoke any statistically significant changes in Gai2 expression (IV, Figure
2B). This outcome is in line with a previous report on rat myometrium,
showing that estradiol administration could increase the levels of both Gai2
protein and Gai2 mRNA during pregnancy (Cohen-Tannoudji et al., 1995).
Regarding the results from study III, which showed a significant increase
in Gai2 gene expression in human endometrium during the menstrual cycle
(Mönkkönen et al., 2007a), it seems likely that the increase observed at that
time might result from concentration peak of estrogen during the late
proliferative phase. Previously, progesterone treatment has been reported to
have no effect on Gai2 expression in rat myometrium during pregnancy
(Cohen-Tannoudji et al., 1995) which is in agreement with the present
findings. The fact that estrogen can regulate epithelial cell differentiation,
and ciliogenesis (Verhage et al., 1979; Donnez et al., 1985), seems relevant
in the light of these findings, since the simultaneous upregulation of Gai2
might be important for the developing oviductal cilia.
   The expression of the novel membrane receptors for progesterone were
studied, as they represent potential signalling partners for Gai2. Both mPRa
and mPRb were found to be expressed in the OE-E6/E7 cell line (IV,
Figure 4A, B). However, the expression level of mPRb was very low and
not sufficient to permit a more detailed analysis. In contrast, potential
effects of sex hormones on mPRa gene expression were studied using
quantitative real time PCR on the cDNA in the hormone treated OE-E6/E7
cell line. There was down-regulation of mPRa gene expression with an
estradiol concentration of 1 nM (IV, Figure 5A), and up-regulation at
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100nM progesterone concentration (IV, Figure 5B). Other concentrations
showed no changes compared to control. Previously, both mPRa and
mPRb have been reported to be up-regulated by 100 nM estradiol, and
mPRa also to be up-regulated by 100 nM progesterone and estradiol-
progesterone combination (Karteris et al., 2006). The present data on 100
nM progesterone-induced mPRa up-regulation are in line with these
previous findings. However, the down-regulation of mPRa seen with 1 nM
estradiol, and the failure to detect any effect on mPRa expression at 100
nM differs from the earlier reported data, which described mPRa up-
regulation at 100nM estradiol treatment. Explanatory factors to account for
these differences could be the different cell types used, and thus, the
variable repertoire of transcriptional factors. Alternatively, differences in
estradiol concentrations and treatment times might explain the difference,
since Karteris et al. used acute, 4-16 hour-treatments, while here the OE-
E6/E7 cell line was cultured with hormones for 5 days.
   The expression of sex hormone receptors, which represent the potential
players mediating the hormone regulation in OE-E6/E7 cell line, were
studied using PCR. The results show that only one nuclear receptor target
for estrogen is present, namely ERb (IV, Figure 3B), since no ERa
receptor expression was detected (IV, Figure 3A). This outcome was
verified using cDNA of human Fallopian tube tissue and endometrium as
positive controls (IV, Figure 3A). In rat oviduct epithelium, only the ERa
subtype is expressed (Fitzpatrick et al., 1999; Sar and Welsch, 1999;
Pelletier et al., 2000), but immunolocalization studies in human have
demonstrated both estrogen receptors, ERa and ERb, to be present in
Fallopian tube epithelial cells (Taylor and Al-Azzawi, 2000). Previously,
limited ERa gene expression was found in OE-E6/E7 cell line, but the ERa
protein was not detected (Lee et al., 2001). There is the possibility, that the
ERa transcript has been lost during the passage of these cells. It is possible
that ERb can be involved in mediating the hormonal regulation of Gai2 and
mPRa, which was observed by quantitative real time PCR. However, no
direct conclusions regarding ERb-mediated regulation of Gai2 and mPRa
genes in human in vivo can be drawn based on these data.
   With respect to progesterone, nuclear receptor targets were found in OE-
E6/E7 cell line (IV, Figure 4C, D), since the PR-B receptor subtype, as
well as a PCR product common to PR-A and PR-B subtypes were found to
be expressed in OE-E6/E7 cell line with very similar expression levels.
Both PR-A and PR-B are products of a single gene, with the only
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difference between these two receptors being the additional 165 amino
acids present solely in the N-terminus of the PR-B subtype. Since the
expression level of PR-B was similar to that obtained with the primer pair
recognising both PR-A and PR-B receptor subtypes, it was concluded that
PR-B is the main nuclear PR receptor in these cells, and thus, might be
responsible for the progesterone-induced genomic functions, namely the
mPRa up-regulation, observed in this study.
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7 CONCLUSIONS
This study aimed to clarify the physiological role of G protein subunit Gai2
in ciliated tissues and to uncover the mechanisms controlling ependymal
ciliary function. The main conclusions are as follows:
1. Gai2 regulates CSF homeostasis in rat brain in vivo and CBF
in rat brain ependymal cells in vitro.
2. Rat brain ependymal ciliary function is regulated by
PACAP27 in a receptor-mediated manner. It seems that a
cAMP-dependent pathway is involved in the regulation of
ciliary amplitude.
3. Gai2 localizes in female reproductive tissues in human,
including endometrium and Fallopian tube epithelium, with
specific enrichment in the Fallopian tube cilia.
4. In human endometrium, the expression of Gai2 follows
hormonal regulation during the menstrual cycle. Estradiol is
involved in Gai2 upregulation in immortalised human
oviductal epithelial cell line OE-E6/E7, but progesterone has
no significant regulatory effect on Gai2 expression.
In summary, Gai2 has a cilia-related physiological role in rat brain and it is
hormonally regulated in the human female reproductive tract.
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